Class information for:
Level 1: ANNEXIN V//APOPTOSIS IMAGING//TC 99M ANNEXIN V

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
15196 726 40.5 91%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
441 3       TRAIL//SURVIVIN//APOPTOSIS 26474
2106 2             GAS6//AXL//MFG E8 5138
15196 1                   ANNEXIN V//APOPTOSIS IMAGING//TC 99M ANNEXIN V 726

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANNEXIN V authKW 776809 15% 16% 112
2 APOPTOSIS IMAGING authKW 467483 2% 65% 17
3 TC 99M ANNEXIN V authKW 432597 2% 86% 12
4 APOSENSE authKW 252350 1% 100% 6
5 ZINCII DIPICOLYLAMINE authKW 252350 1% 100% 6
6 ZINC DIPICOLYLAMINE authKW 168233 1% 100% 4
7 BAVITUXIMAB authKW 134585 1% 80% 4
8 TC 99M DURAMYCIN authKW 134585 1% 80% 4
9 TC 99M HYNIC ANNEXIN V authKW 126175 0% 100% 3
10 INT NRW CHEM address 126169 1% 50% 6

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Radiology, Nuclear Medicine & Medical Imaging 4488 31% 0% 224
2 Biochemical Research Methods 889 12% 0% 90
3 Chemistry, Medicinal 317 7% 0% 50
4 Oncology 299 12% 0% 90
5 Cell Biology 287 12% 0% 87
6 Biochemistry & Molecular Biology 202 18% 0% 130
7 Chemistry, Organic 195 9% 0% 65
8 Chemistry, Multidisciplinary 179 13% 0% 94
9 Medicine, Research & Experimental 112 6% 0% 42
10 Nanoscience & Nanotechnology 29 3% 0% 23

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INT NRW CHEM 126169 1% 50% 6
2 MED SIGNAL 84117 0% 100% 2
3 JIANGSU TARGET PHARMA S INC 75703 0% 60% 3
4 TRANSLAT NUCL MED MOL IMAGING 58407 1% 28% 5
5 FERDOUS NUCL MED 56076 0% 67% 2
6 HAMON CANC 56072 1% 33% 4
7 GLAUCOMA RETINAL NEURODEGENERAT GRP 48061 1% 29% 4
8 AG MOL IMAGING 42058 0% 100% 1
9 BEPHROL HYERTENS TRANSPLANTAT 42058 0% 100% 1
10 BRIGHT CELL BIOL PHYSIOL 42058 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MOLECULAR IMAGING 23843 2% 4% 16
2 NUCLEAR MEDICINE AND BIOLOGY 13977 5% 1% 35
3 JOURNAL OF NUCLEAR MEDICINE 9911 7% 0% 49
4 MOLECULAR IMAGING AND BIOLOGY 7378 2% 1% 13
5 PEZCOLLER FOUNDATION SYMPOSIA 6727 2% 1% 18
6 BIOCONJUGATE CHEMISTRY 6121 4% 1% 27
7 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 5771 3% 1% 21
8 THERANOSTICS 2572 1% 1% 6
9 EJNMMI RESEARCH 2391 1% 1% 5
10 QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 1937 1% 1% 5

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ANNEXIN V 776809 15% 16% 112 Search ANNEXIN+V Search ANNEXIN+V
2 APOPTOSIS IMAGING 467483 2% 65% 17 Search APOPTOSIS+IMAGING Search APOPTOSIS+IMAGING
3 TC 99M ANNEXIN V 432597 2% 86% 12 Search TC+99M+ANNEXIN+V Search TC+99M+ANNEXIN+V
4 APOSENSE 252350 1% 100% 6 Search APOSENSE Search APOSENSE
5 ZINCII DIPICOLYLAMINE 252350 1% 100% 6 Search ZINCII+DIPICOLYLAMINE Search ZINCII+DIPICOLYLAMINE
6 ZINC DIPICOLYLAMINE 168233 1% 100% 4 Search ZINC+DIPICOLYLAMINE Search ZINC+DIPICOLYLAMINE
7 BAVITUXIMAB 134585 1% 80% 4 Search BAVITUXIMAB Search BAVITUXIMAB
8 TC 99M DURAMYCIN 134585 1% 80% 4 Search TC+99M+DURAMYCIN Search TC+99M+DURAMYCIN
9 TC 99M HYNIC ANNEXIN V 126175 0% 100% 3 Search TC+99M+HYNIC+ANNEXIN+V Search TC+99M+HYNIC+ANNEXIN+V
10 ANNEXIN A5 116794 3% 14% 20 Search ANNEXIN+A5 Search ANNEXIN+A5

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ZENG, WB , WANG, XB , XU, PF , LIU, G , EDEN, HS , CHEN, XY , (2015) MOLECULAR IMAGING OF APOPTOSIS: FROM MICRO TO MACRO.THERANOSTICS. VOL. 5. ISSUE 6. P. 559 -582 109 55% 11
2 VANGESTEL, C , PEETERS, M , MEES, G , OLTENFREITER, R , BOERSMA, HH , ELSINGA, PH , REUTELINGSPERGER, C , VAN DAMME, N , DE SPIEGELEER, B , VAN DE WIELE, C , (2011) IN VIVO IMAGING OF APOPTOSIS IN ONCOLOGY: AN UPDATE.MOLECULAR IMAGING. VOL. 10. ISSUE 5. P. 340 -358 66 75% 10
3 BLANKENBERG, FG , (2008) IN VIVO DETECTION OF APOPTOSIS.JOURNAL OF NUCLEAR MEDICINE. VOL. 49. ISSUE . P. 81S-95S 73 58% 79
4 SMITH, BA , SMITH, BD , (2012) BIOMARKERS AND MOLECULAR PROBES FOR CELL DEATH IMAGING AND TARGETED THERAPEUTICS.BIOCONJUGATE CHEMISTRY. VOL. 23. ISSUE 10. P. 1989 -2006 91 44% 34
5 FAUST, A , HERMANN, S , WAGNER, S , HAUFE, G , SCHOBER, O , SCHAFERS, M , KOPKA, K , (2009) MOLECULAR IMAGING OF APOPTOSIS IN VIVO WITH SCINTIGRAPHIC AND OPTICAL BIOMARKERS - A STATUS REPORT.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 9. P. 968 -985 72 56% 11
6 BLANKENBERG, FG , (2008) MONITORING OF TREATMENT-INDUCED APOPTOSIS IN ONCOLOGY WITH PET AND SPECT.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 28. P. 2974-2982 52 68% 22
7 BOERSMA, HH , KIETSELAER, BLJH , STOLK, LML , BENNAGHMOUCH, A , HOFSTRA, L , NARULA, J , HEIDENDAL, GAK , REUTELINGSPERGER, CPM , (2005) PAST, PRESENT, AND FUTURE OF ANNEXIN A5: FROM PROTEIN DISCOVERY TO CLINICAL APPLICATIONS.JOURNAL OF NUCLEAR MEDICINE. VOL. 46. ISSUE 12. P. 2035-2050 47 63% 189
8 KUGE, Y , ZHAO, S , TAKEI, T , TAMAKI, N , (2009) MOLECULAR IMAGING OF APOPTOSIS WITH RADIO-LABELED ANNEXIN A5 FOCUSED ON THE EVALUATION OF TUMOR RESPONSE TO CHEMOTHERAPY.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 9. P. 1003-1011 50 66% 4
9 DE SAINT-HUBERT, M , BAUWENS, M , VERBRUGGEN, A , MOTTAGHY, FM , (2012) APOPTOSIS IMAGING TO MONITOR CANCER THERAPY: THE ROAD TO FAST TREATMENT EVALUATION?.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 13. ISSUE 4. P. 571-583 43 63% 11
10 BLANKENBERG, FG , (2008) IN VIVO IMAGING OF APOPTOSIS.CANCER BIOLOGY & THERAPY. VOL. 7. ISSUE 10. P. 1525 -1532 49 60% 27

Classes with closest relation at Level 1


Rank Class id link
1 36759 PHARMACEUT CARE CLIN PHARM//BISABOLOLOXIDE A//INTRACELLULAR ZN2
2 8727 APOPTOTIC CELLS//CELL CLEARANCE//PHAGOCYTOSIS
3 36148 EFFECTIVE ABSORBED DOSE//TC 99M DTPA DG//2 AMINO DEOXY D GLUCOSE
4 29940 CHARGE CHANGING SUBSTRATE//IN GEL PROTEASE ACTIVITY ASSAY//SUBSTRATE SPECIFIC ZYMOGRAPHY
5 11757 APOPTOSIS//APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN ARC//BAX DEFICIENT HEARTS
6 10368 TRANSLAT MOL IMAGING//IMAGING SCI S//MOLECULAR IMAGING
7 21418 ANTIMYOSIN ANTIBODY//TC 99M GLUCARATE//ANTIMYOSIN
8 26066 MFG E8//LACTADHERIN//MEDIN
9 16628 F 18 FLT//FLT//FLUOROTHYMIDINE
10 22928 LASER SCANNING CYTOMETRY//MOL PATTERN RECOGNIT GRP//LASER SCANNING CYTOMETRY LSC

Go to start page